Milestone Pharmaceuticals Inc. (MIST)
0.77
0.00 (0.00%)
Upcoming Events
Latest Headlines
Milestone Pharmaceuticals enrolls first European patient in AFib trial
October 9, 2026 8:00 AM - StreetInsider
Milestone Pharmaceuticals Announces First European Study Participant Enrolled in ReVeRA-301 Phase 3 Clinical Trial
October 9, 2026 8:00 AM - Globe NewsWire
Milestone Pharmaceuticals enrolls first Canadian patient in AFib trial
September 24, 2026 8:01 AM - StreetInsider
Milestone Pharmaceuticals Enrolls First Canadian Study Participant in ReVeRA-301 Phase 3 Pivotal Trial Evaluating Etripamil Nasal Spray for AFib-RVR
September 24, 2026 8:00 AM - Globe NewsWire
H.C. Wainwright Reiterates Buy Rating on Milestone Pharmaceuticals (MIST)
September 4, 2026 6:46 AM - StreetInsider
Milestone study finds PSVT impacts patient life between episodes
August 27, 2026 8:01 AM - StreetInsider
Milestone Pharmaceuticals Announces Data Presented at ESC Congress 2026 on the Impact of Paroxysmal Supraventricular Tachycardia (PSVT) on Patients’ Daily Lives and Quality of Life Between Episodes
August 27, 2026 8:00 AM - Globe NewsWire
Milestone Pharmaceuticals starts Phase 3 AFib-RVR trial for etripamil
August 21, 2026 8:00 AM - StreetInsider
Milestone Pharmaceuticals Initiates Pivotal Phase 3 Trial of Etripamil Nasal Spray for Self-Administered Treatment of Atrial Fibrillation with Rapid Ventricular Rate (AFib-RVR)
August 21, 2026 8:00 AM - Globe NewsWire
Cantor Fitzgerald Starts Milestone Pharmaceuticals (MIST) at Overweight
August 20, 2026 6:08 AM - StreetInsider
Form 8-K Milestone Pharmaceutical For: Aug 12
August 12, 2026 7:29 AM - SEC Filing
Milestone Pharmaceuticals Inc. (MIST) Misses Q2 EPS by 2c
August 12, 2026 7:16 AM - StreetInsider
Milestone Pharmaceuticals Announces Second Quarter 2026 Financial Results and Provides Corporate Update
August 12, 2026 7:08 AM - Globe NewsWire
Form 10-Q Milestone Pharmaceutical For: Jun 30
August 12, 2026 7:01 AM - SEC Filing
Form SCHEDULE 13G Milestone Pharmaceutical Filed by: Pavaki Capital Management LLC
August 7, 2026 1:50 PM - SEC Filing
Milestone Pharmaceuticals to Announce Second Quarter 2026 Financial Results on August 12, 2026
August 4, 2026 4:01 PM - Globe NewsWire
Raymond James sees potential for beats across biopharma coverage
July 21, 2026 6:12 AM - StreetInsider
Full Article List
